Bellerophon Therapeutics, Inc. in its Annual meeting of shareholders held on June 1, 2022 elected Mary Ann Cloyd and Crispin Teufel to serve on the Company's board of directors for a three-year term until the Company's 2025 annual meeting of stockholders and until each of their respective successors is duly elected and qualified.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0606 USD | -2.94% | +7.64% | +63.78% |
May. 02 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 25 | North American Morning Briefing : More Tech -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
+63.78% | 764K | |
+8.21% | 115B | |
+13.10% | 107B | |
-13.63% | 22.31B | |
-3.99% | 21.6B | |
-5.60% | 18.23B | |
-39.93% | 17.62B | |
+7.36% | 14.26B | |
+33.53% | 12.37B | |
-28.37% | 8.28B |
- Stock Market
- Equities
- BLPH Stock
- News Bellerophon Therapeutics, Inc.
- Bellerophon Therapeutics, Inc. Announces New Board Appointment